Results of the cross-Canada survey of recombinant human erythropoietin (r-HuEPO) therapy programs. The Medicine Group (Canada) Ltd.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002170:Canada; D002648:Child; D002675:Child, Preschool; D016527:Drug Costs; D004363:Drug Utilization; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000451:nursing; D008875:Middle Aged; D010353:Patient Education as Topic; D011795:Surveys and Questionnaires
D004921:Erythropoietin